HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Current developments in the laboratory diagnosis of rubella].

Abstract
Thirty years after the introduction of the hemagglutination inhibition assay (HAI), laboratory diagnosis of rubella virus infection has achieved a high reliability. While the HAI remains the reference standard against which newer assays are compared, routine laboratory diagnosis is based mainly on ELISA tests which permit a more rapid and less cumbersome detection of specific IgG and IgM antibody. Although quantification of immunoglobulin G against rubella virus is performed using WHO standards, the correlation between different ELISAs is relatively poor. Despite substantial improvements in virus isolation and nucleic acid amplification techniques, serology remains the mainstay of diagnosis for both acquired and postnatal diagnosis of congenital infection. Differentiation between primary and re-infection is of critical importance during pregnancy and can be achieved relatively reliably by antibody avidity determination or by immunoblot. While current anti-rubella IgM ELISAs are relatively sensitive, their specificity may be limited by cross reactivity with other viruses, i.e. parvovirus B19 and Epstein-Barr virus. Maternal reinfection with congenital rubella syndrome is very rare, however it may be misdiagnosed in the absence of significant IgG antibody titer change and/or IgM antibody.
AuthorsB Weber
JournalBulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg (Bull Soc Sci Med Grand Duche Luxemb) Vol. 134 Issue 2 Pg. 31-41 ( 1997) ISSN: 0037-9247 [Print] Luxembourg
Vernacular TitleAktuelle Entwicklungen in der Labordiagnose der Röteln.
PMID9534272 (Publication Type: English Abstract, Journal Article, Review)
Topics
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Hemagglutination Tests
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Pregnancy Complications, Infectious (epidemiology)
  • Reproducibility of Results
  • Rubella (diagnosis, transmission)
  • Rubella Syndrome, Congenital (epidemiology)
  • World Health Organization

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: